DUALITYBIO-B (09606) plans to issue RMB shares and list on the Science and Technology Innovation Board, raising no more than 6.75 billion yuan.

date
22:46 13/04/2026
avatar
GMT Eight
Ying En Bio-B (09606) announced that on April 13, 2026, the board of directors approved the proposal to issue RMB shares on the Science and Technology Innovation Board, special authorization, and related matters. These actions are subject to approval by the shareholders at an extraordinary general meeting and obtaining necessary regulatory approvals before implementation. The total amount of funds to be raised from the issuance of RMB shares is expected to not exceed RMB 6.75 billion. After deducting issuance expenses, the net proceeds will be used in full for projects related to the company's main business.
DUALITYBIO-B (09606) announced that on April 13, 2026, the board of directors approved the proposal to issue RMB shares on the Science and Technology Innovation Board, special authorization, and related matters. This proposal must be approved by shareholders at a special general meeting and obtain necessary regulatory approvals before it can be implemented. The total amount of funds to be raised from the issuance of RMB shares is expected to be no more than RMB 6.75 billion. After deducting issuance expenses, the net proceeds will be used entirely for projects related to the company's core business. The company proposes to issue no more than 15,779,190 RMB shares, and the company and lead underwriters may agree to use the over-allotment option. Accordingly, the number of RMB shares to be issued will not exceed 15% of the initial number of RMB shares to be issued.